AU592463B2 - Active material combination with antithrombotic action - Google Patents

Active material combination with antithrombotic action Download PDF

Info

Publication number
AU592463B2
AU592463B2 AU76282/87A AU7628287A AU592463B2 AU 592463 B2 AU592463 B2 AU 592463B2 AU 76282/87 A AU76282/87 A AU 76282/87A AU 7628287 A AU7628287 A AU 7628287A AU 592463 B2 AU592463 B2 AU 592463B2
Authority
AU
Australia
Prior art keywords
active material
diltiazem
acetylsalicylic acid
acid
material combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU76282/87A
Other languages
English (en)
Other versions
AU7628287A (en
Inventor
Hartmut Prof. Dr. Osswald
Gerhard Dr. Satzinger
Ute Weiershausen
Gunter Dr. Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of AU7628287A publication Critical patent/AU7628287A/en
Application granted granted Critical
Publication of AU592463B2 publication Critical patent/AU592463B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AU76282/87A 1986-07-31 1987-07-30 Active material combination with antithrombotic action Ceased AU592463B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863626097 DE3626097A1 (de) 1986-07-31 1986-07-31 Wirkstoffkombination enthaltend diltiazem und acetylsalicylsaeure
DE3626097 1986-07-31

Publications (2)

Publication Number Publication Date
AU7628287A AU7628287A (en) 1988-02-04
AU592463B2 true AU592463B2 (en) 1990-01-11

Family

ID=6306505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76282/87A Ceased AU592463B2 (en) 1986-07-31 1987-07-30 Active material combination with antithrombotic action

Country Status (12)

Country Link
US (1) US4724266A (enExample)
EP (1) EP0255141B1 (enExample)
JP (1) JPS6335522A (enExample)
KR (1) KR880001293A (enExample)
AT (1) ATE77746T1 (enExample)
AU (1) AU592463B2 (enExample)
CA (1) CA1285938C (enExample)
DE (2) DE3626097A1 (enExample)
ES (1) ES2038139T3 (enExample)
GR (1) GR3005096T3 (enExample)
PH (1) PH24931A (enExample)
ZA (1) ZA875688B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049655C (en) * 1990-09-17 1996-11-12 Akio Odawara Pharmaceutical composition for inhibiting platelet aggregation
JP2712144B2 (ja) * 1992-02-06 1998-02-10 田辺製薬株式会社 血小板凝集抑制組成物
JP2712143B2 (ja) * 1992-12-22 1998-02-10 田辺製薬株式会社 血小板凝集抑制組成物
AU2023401A (en) * 1999-12-01 2001-06-12 Natco Pharma Limited A rapid acting freeze dired oral pharmaceutical composition for treating migraine
EP1881821B1 (en) * 2005-05-20 2016-11-09 Omeros Corporation Compositions comprising ketoprofen and calcium channel antagonist for use in urological procedures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
FR2589358B1 (fr) * 1985-07-30 1987-12-04 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'aspirine

Also Published As

Publication number Publication date
US4724266A (en) 1988-02-09
KR880001293A (ko) 1988-04-22
PH24931A (en) 1990-12-26
GR3005096T3 (enExample) 1993-05-24
EP0255141B1 (de) 1992-07-01
EP0255141A2 (de) 1988-02-03
JPS6335522A (ja) 1988-02-16
EP0255141A3 (en) 1989-11-15
DE3626097A1 (de) 1988-02-11
CA1285938C (en) 1991-07-09
DE3780095D1 (de) 1992-08-06
ES2038139T3 (es) 1993-07-16
ZA875688B (en) 1988-04-27
AU7628287A (en) 1988-02-04
ATE77746T1 (de) 1992-07-15

Similar Documents

Publication Publication Date Title
CN1116042C (zh) 含有氯吡格雷和一种抗血栓形成药活性成分的组合物
Hutchison et al. Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate
CA2024188C (en) Method of treating premature ejaculation using sertraline
CA2261099C (fr) Composition pharmaceutique antithrombotique et antiatherogene comprenant un derive de thienopyridine et un inhibiteur de la hmg-coa-reductase
JP3333777B2 (ja) アシルcoa−コレステロール−o−アシルトランスフェラーゼ抑制剤、動脈壁上でのマクロファージ−脂質複合体蓄積の抑制剤および肝疾患予防または治療剤としての柑橘類果皮抽出物
US7135196B2 (en) Iron compositions
RU2211224C2 (ru) Синтетические полисахариды, способ их получения и содержащие их фармацевтические композиции
ATE315391T1 (de) Präparat zur behandlung von bluthochdruck.
WO2000064470A1 (en) A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
CA1285938C (en) Active material combination with antithrombotic action
Osborne et al. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits
JPS6229525A (ja) デイルチアゼムおよびアスピリンを主成分とする血小板凝集阻害剤
IE47144B1 (en) Treatment of swine dysentery
US3966978A (en) 4-Biphenylacetic acid as an inhibitor of platelet aggregation
Bennett et al. Antifibrinolytic treatment in haemophilia: a controlled trial of prophylaxis with tranexamic acid
US5102883A (en) Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
JPS63246333A (ja) 抗パントテン酸欠亡成分を主剤とする腸管活性型ソフトカプセル製剤
EP0000254B1 (en) Antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions
JPS5936890B2 (ja) 制癌剤
EP1270001A1 (en) Pharmaceutical composition containing calcium acetate and calcium carbonate
EP0001503B1 (en) Antithrombotic compositions containing benzisothiazolones
Verhaegen et al. Rupture of vascular prosthesis in a patient with Yersinia enterocolitica bacteremia
US4195089A (en) Synergistic composition for malaria
US3721738A (en) Treatment and prophylaxis of thrombovascular diseases with 2-imidazolone derivatives
US5786376A (en) Methods of treating opportunistic infections with azaspiranes